LDLR and acute myeloid leukemia: We observed that acute myeloid leukemia (AML) OCI-AML3 cells growing in OXPHOS medium for 2 weeks, such as those treated with DCA, presented an increase of ERK5 and LDLR mRNA (Supplemental Fig. 2A), LDLR protein and LDL intake (Fig. 1D).